Home / Drug shortages / Azithromycin Injection

Azithromycin Injection — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Azithromycin Injection (injection) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on 01/20/2026.

Shortage Details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0069-3150-83
Dosage Form
Injection
Presentation
Zithromax IV, Injection, 500 mg/5 mL (NDC 0069-3150-83)
Initial Posting
01/20/2026
Revised Date

FDA data resources